The biggest splash this week came from Novavax, a Maryland company that landed $1.6 billion from the US government’ s Operation Warp Speed program to support manufacturing and clinical trials for its vaccine candidate. At least three key clinical studies are expected to begin later this month: Moderna’ s new trial of its experimental vaccine, which would be the…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Best’s Market Segment Outlook: AM Best’s Outlook on Germany’s Non-Life Insurance Market Remains Stable
Advisor News
- It’s a new year: How will you reinvigorate your client service?
- Trump should impose China tariffs, prioritize renewing tax cuts and immigration reform
- Fewer report having retirement savings than a year ago
- Paul Brahim becomes 2025 FPA president
- How can people tell if you are sincere?
More Advisor NewsAnnuity News
- Salt Financial Annuity Index analytics report for 2024
- Ibexis Life & Annuity Insurance Company® Launches WealthDefender™ Fixed Index Annuity Series
- AmeriLife To Acquire Crump Life Insurance Services
- Sapiens wins XCelent award for Customer Base and Support for UnderwritingPro for Life & Annuities
- SB 263 expected to bring chaos to Calif. insurance, annuity sales come Jan. 1
More Annuity NewsHealth/Employee Benefits News
- Obamacare enrollment hits record before Trump’s return
- Once again, Florida leads the nation in Obamacare enrollment
- Medicare Advantage open enrollment lasts through March 31
- ACA hits record enrollment days ahead of sign-up deadline
- Health insurers limit coverage of prosthetic limbs
More Health/Employee Benefits NewsLife Insurance News
- Registration Statement by Closed End Investment Company (Form N 2ASR)
- U-Haul Holding Company to Participate in KeyBanc Capital Markets Self-Storage Investor Forum
- National Life: plaintiff promotes ‘odd theory’ in IUL lawsuit over 0% return
- Ethos and Protective Collaborate to Offer Term Life Insurance
- UnitedHealth ordered to pay $165M for deceiving costumers
More Life Insurance News